Findings from a head-to-head trial comparing Victoza® (liraglutide) and lixisenatide, both in combination with metformin, demonstrated a significantly greater reduction in HbA1c of -1.83% for liraglutide vs -1.21% for lixisenatide in adults with type 2 diabetes (Novo Nordisk)
Diabetes News
Tag: Victoza
New study with Victoza® (liraglutide) showed improvements in blood glucose control in adults with type 2 diabetes who fasted during Ramadan
New findings showed that adults with type 2 diabetes treated with Victoza®, in combination with metformin, experienced similar improvements in blood glucose control while fasting during Ramadan (four weeks) compared with sulfonylurea (SU) plus metformin (Novo Nordisk)
Glycosmedia is also available as an App: